Intimation of Schedule of the Analysts Conference Call for Q4 results and audited financials for FY2026
AKUMS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Akums Drugs and Pharmaceuticals has scheduled a virtual investors conference call on May 18, 2026 at 12:00 PM IST to discuss Q4 and full year FY2026 results. The call will be attended by Managing Directors Sanjeev Jain and Sandeep Jain, CFO Sumeet Sood, and Head of Strategy Sahil Maheshwari. ICICI Securities is coordinating the call with dial-in details provided for global access. The company has explicitly stated that no unpublished price sensitive information will be shared during the meet.
This is a routine investor relations disclosure under SEBI regulations. The scheduled earnings call is positive for transparency but does not signal any material news. Shareholders can use this call to hear management's outlook and ask questions about FY2026 performance.